Wancheng Guo1,2, Christopher Strouse3, David Mery1

  • 1Myeloma Center, Department of Internal Medicine, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W. Markham St. Slot# 508, Little Rock, AR 72205, USA.

Cancers
|March 28, 2024
PubMed
概括

这项研究确定了影响多发性骨髓瘤 (MM) 患者在自身干细胞移植 (ASCT) 后结果的关键因素. 一个新的分期系统 (ATM4S) 使用这些因素来预测预后和个性化MM治疗.